Any long term owner of this stock should revel in this low stock price.
Management has had their foot down on the buyback over the last three months. In October they bought back over 2 million shares alone. A low stock price will simply allow them to spend less on these purchases and will translate into a higher stock price down the road.
That said, they do need to flatten out their production. Growth in BOPD is not needed for this stock to go up, they just need to stop the bleeding. Octobers' bump in production over September leads me to believe this is in the process of occuring.
Cheers,
A Patient Bull.